resazurin has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jank, BJ; Lanuti, M; Mathisen, DJ; Ott, HC; Ren, X; Tapias, LF | 1 |
Casey, A; Chambers, G; Murphy, A; Sheehy, K | 1 |
2 other study(ies) available for resazurin and Lung Neoplasms
Article | Year |
---|---|
Ex vivo non-invasive assessment of cell viability and proliferation in bio-engineered whole organ constructs.
Topics: Animals; Bioengineering; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Endothelial Progenitor Cells; Human Umbilical Vein Endothelial Cells; Humans; Indicators and Reagents; Lung; Lung Neoplasms; Male; Organ Culture Techniques; Oxazines; Perfusion; Rats, Sprague-Dawley; Regeneration; Tissue Engineering; Tissue Scaffolds; Xanthenes | 2015 |
The surfactant dipalmitoylphophatidylcholine modifies acute responses in alveolar carcinoma cells in response to low-dose silver nanoparticle exposure.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adenocarcinoma, Bronchiolo-Alveolar; Cell Line, Tumor; Cell Survival; Coloring Agents; Humans; Inflammation; Lung Neoplasms; Metal Nanoparticles; Oxazines; Reactive Oxygen Species; Silver; Tetrazolium Salts; Thiazoles; Tumor Stem Cell Assay; Xanthenes | 2015 |